Who owns ORAMED PHARMACEUTICALS INC.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of ORMP from SEC Form 13F filings across 84 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 84 institutions disclosed 16.8M shares of ORAMED PHARMACEUTICALS INC. worth $80.7M — about 40.9% of shares outstanding; the largest disclosed holder is MERCER GLOBAL ADVISORS INC /ADV. Source: SEC Form 13F filings, parsed by EvidInvest.
84
13F holders
$80.7M
value, 2026 filers
40.9%
of shares outstanding (16.8M sh)
29
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of ORMP's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | MERCER GLOBAL ADVISORS INC /ADV | 3.8M | $18.3M | 0.0% | 9.3% | +99.4% |
| 2 | Aquamarine Financial (Cayman) Ltd | 2.5M | $12.1M | 0.7% | 6.1% | +18.9% |
| 3 | Gem Investment Advisors, LLC | 2.0M | $9.6M | 5.9% | 4.9% | +21.9% |
| 4 | BlackRock, Inc. | 1.6M | $7.7M | 0.0% | 3.9% | +1644.3% |
| 5 | Murchinson Ltd. | 1.3M | $6.2M | 0.9% | 3.1% | -1.9% |
| 6 | BML Capital Management, LLC | 866,269 | $4.2M | 2.4% | 2.1% | -72.6% |
| 7 | BOOTHBAY FUND MANAGEMENT, LLC | 578,638 | $2.8M | 0.0% | 1.4% | -3.7% |
| 8 | GEODE CAPITAL MANAGEMENT, LLC | 500,690 | $2.4M | 0.0% | 1.2% | +1962.0% |
| 9 | GOLDMAN SACHS GROUP INCNEW | 253,293 | $1.2M | 0.0% | 0.6% | new |
| 10 | STATE STREET CORPNEW | 242,100 | $1.2M | 0.0% | 0.6% | new |
| 11 | Rathbones Group PLC | 233,018 | $1.1M | 0.0% | 0.6% | 0.0% |
| 12 | VANGUARD PORTFOLIO MANAGEMENT LLCNEW | 229,882 | $1.1M | 0.0% | 0.6% | new |
| 13 | DIMENSIONAL FUND ADVISORS LP | 202,609 | $973,782 | 0.0% | 0.5% | +28.1% |
| 14 | NORTHERN TRUST CORPNEW | 184,920 | $889,465 | 0.0% | 0.5% | new |
| 15 | RENAISSANCE TECHNOLOGIES LLC | 183,800 | $884,078 | 0.0% | 0.4% | +24.4% |
| 16 | WELLS FARGO & COMPANY/MN | 166,000 | $798,458 | 0.0% | 0.4% | +5.3% |
| 17 | BANK OF AMERICA CORP /DE/ | 150,694 | $724,838 | 0.0% | 0.4% | +3.1% |
| 18 | STRS OHIONEW | 133,800 | $643,578 | 0.0% | 0.3% | new |
| 19 | JANE STREET GROUP, LLC | 113,349 | $545,209 | 0.0% | 0.3% | +115.7% |
| 20 | O'SHAUGHNESSY ASSET MANAGEMENT, LLC | 102,962 | $495,247 | 0.0% | 0.3% | -11.5% |
| 21 | MARSHALL WACE, LLP | 101,953 | $490,393 | 0.0% | 0.2% | -60.7% |
| 22 | HRT FINANCIAL LP | 97,582 | $469,000 | 0.0% | 0.2% | +254.9% |
| 23 | Hillsdale Investment Management Inc. | 89,300 | $429,533 | 0.0% | 0.2% | -8.2% |
| 24 | RITHOLTZ WEALTH MANAGEMENT | 84,347 | $405,709 | 0.0% | 0.2% | -45.8% |
| 25 | CHARLES SCHWAB INVESTMENT MANAGEMENT INCNEW | 83,634 | $402,280 | 0.0% | 0.2% | new |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.